PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers

Tools and methods for expression of membrane proteins

Vesicular stomatitis viruses

Optogenetic inhibition of overactive neuronal activity

Coiled-coil connector

Transferrin receptor transgenic models

Immunity to folate receptors

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

Method for in vivo expansion of T regulatory cells

Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1

Use of chimeric antigen receptor modified cells to treat cancer

Methods for treating neurodegenerative disease using anti-PD-1 antibodies

ANTIBODY THAT BINDS MURINE WISE PROTEIN

Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems and methods

Methods for treating neurodegenerative diseases using anti-PD-L1 antibodies

Diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females)

Identification of novel anti-fibrotic peptide in C-terminal region of the MET receptor tyrosine kinase

IMMUNOTHERAPY WITH BINDING AGENTS

Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids

Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same

METHODS OF IDENTIFYING, ISOLATING AND USING ODORANT AND AROMA RECEPTORS

Binding-triggered transcriptional switches and methods of use thereof

HDL THERAPY MARKERS

Methods of treating pain using anti-GPR160 antibodies

METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTORS AND ADAPTORS THEREOF

Compositions and methods to modulate cell activity

Multi-ligand drug conjugates and uses thereof

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

ALBUMIN FUSION PROTEINS

Method and compositions for cellular immunotherapy

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

Etanercept formulations stabilized with combinations of sugars and polyols

Methods for identification, assessment, prevention, and treatment of metabolic disorders using Slit2

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

Compositions and methods related to engineered erythroid cells comprising IL-15

COMPOSITIONS AND METHODS RELATED TO MULTIMODAL THERAPEUTIC CELL SYSTEMS FOR AUTOIMMUNE INDICATIONS

TRANSGENIC PIGS WITH GENETIC MODIFICATIONS OF SLA

Universal biosensor system for analyte detection

TOLL-LIKE RECEPTOR 3 ANTAGONISTS

Redirected cells with MHC chimeric receptors and methods of use in immunotherapy

METHODS FOR TREATING NEURAL CELL SWELLING

Microorganism for expressing a human membrane protein

Peptide conjugated hydrogel substrate for the maintenance and expansion of human pluripotent stem cells

STAPLED PEPTIDES AND USES THEREOF

T cell receptors and immune therapy using the same

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

CD137 binding fibronectin type III domains

PD-L1 binding fibronectin type III domains

T cell receptors and immune therapy using the same

Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells

MULTIMERIC CONSTRUCTS

Masking chimeric antigen receptor T cells for tumor-specific activation

HIV VPR-specific T-cell receptors

Cadherin 26 (CDH26)-Fc fusion proteins and methods of use thereof to treat inflammatory conditions

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

BTN3A ECTODOMAIN PROTEINS AND METHODS OF USE

Inhibitors of mitochondrial fission and methods of use thereof

TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO

Anti-tumor peptides and use thereof

Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease

Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease

Natural killer cell immunotherapy for treating cancer

Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease

PAR1 and PAR2 c-tail peptides and peptide mimetics

Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells

KAI1 PROTEIN CONTROLLING CELL CYCLE OF HEMATOPOIETIC STEM CELL, AND USE THEREOF

METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE A T2R TASTE RECEPTOR

Promoter for the specific expression of genes in Müller cells

Ligand Matched Transcription Control, Control Devices, and Solute Carriers

Method for selecting odor-controlling substance

Etanercept formulations stabilized with metal ions

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor

Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer

COMPOSITIONS COMPRISING RECEPTOR-ASSOCIATED PROTEIN (RAP) VARIANTS SPECIFIC FOR CR-CONTAINING PROTEINS AND USES THEREOF

Compositions containing protein loaded exosome and methods for preparing and delivering the same

COMPOSITIONS AND METHODS FOR GENERATING ANTIGENS, ANTIBODIES, AND IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS

Methods for epitope selection

Treatment of Fibrodysplasia Ossificans Progressiva

Nuclease-mediated regulation of gene expression

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells

Disease model pig exhibiting stable phenotype, and production method thereof

Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner

Method of using transmembrane channel-like protein 6 (TMC6) protein to identify substances affecting salty taste

Compositions and Methods for Diagnosing and Treating Cancer

INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS

Methods and compositions for treating pain

T2R taste receptors and genes encoding same

T1R taste receptors and genes encoding same

Compositions and methods related to engineered erythoid cells comprising 4-1BBL

Chimeric antigen receptor and methods of use thereof

CANCER MARKER AND THE USE THEREOF

Peptide regulators of mitochondrial fusion and methods of use

Cell line stably expressing Nav1.5 and method of screening therapeutic agent using the cell line

Binding-triggered transcriptional switches and methods of use thereof

Compositions and method for reducing seizures

Alpha connexin C-terminal (ACT) peptides and methods of use thereof

TREATMENT OF DIABETES USING AGONISTS OF THE MAS-RELATED GPCR D

Assay with synaptobrevin based moiety

HIGH AFFINITY NY-ESO T CELL RECEPTORS

Backbone-cyclized peptidomimetics with GLP-1R modulating activity

Synthetic platelets

Alpha connexin c-terminal (ACT) peptides and methods of use thereof

Biomarkers for diagnosis and prognosis of corneal ectatic disorders

USE OF TRPC6 MRNA LEVELS IN PERIPHERAL BLOOD CELLS FOR EARLY DETECTION/DIAGNOSIS OF SENILE DEMENTIA

Fusion protein comprising , translation interrupter sequence, and interferon amino acid sequences

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes

Cytokine receptor genes and the use thereof to enhance therapy

MUC1-DERIVED PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER, IMMUNITY-INDUCING AGENT AND METHOD FOR MANUFACTURING ANTIGEN PRESENTING CELL USING SAME

Messenger UNA molecules and uses thereof

Neuropilin-1 specific binding peptide, fusion protein fused with same, and use thereof

Dendrimer conjugates for coating cells

Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domain

Mutant smoothened and methods of using the same

DROSOPHILA MODEL OF HUMAN CERVICAL CANCER

Specific A-beta species-binding peptides for the therapy and/or diagnosis of Alzheimer's dementia

Minimally-invasive and activity-dependent control of excitable cells

Methods of making and using soluble MHC molecules

RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION

Chimeric antigen receptor and methods of use thereof

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS

Gene and mutations thereof associated with seizure and movement disorders

GENE THERAPY TO IMPROVE VISION

GPR156 variants and uses thereof

Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor

NOVEL VOLTAGE-DEPENDENT ION CHANNEL FUSIONS AND METHOD OF USE THEREOF

Etanercept formulations stabilized with xylitol

COMPOSITIONS AND METHODS FOR THERAPEUTIC ANTI-CANCER VACCINATION

Use of toll-like receptor agonist for treating cancer

Compositions and methods for regulating blood pressure

ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH

Engineered T cells and uses therefor

Chimeric antigen receptor signalling system comprising heterodimerization domains

ANTI-TAU CONSTRUCTS

Methods and compositions for modulating toso activity

CFTR MRNA compositions and related methods and uses

Ligand-binding fiber and cell culture substrate using said fiber

Modified ligand-gated ion channels and methods of use

WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES

NOVEL HEMOPOIETIN RECEPTOR PROTEIN, NR10

GLUT-1 AS A RECEPTOR FOR HTLV ENVELOPES AND ITS USES

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

Method for preparing TNFR-Fc fusion protein containing target content of impurities

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants

Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR HEMATOPOIETIC ORIGIN

PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES

Use of ICOS-based CARS to enhance antitumor activity and CAR persistence

CS1 targeted chimeric antigen receptor-modified T cells

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s)

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s)

TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN

Biotinylated and oxidized LDL receptor and advanced glycation end product receptor produced using genetically engineered silkworm

In vivo production of proteins

WATER-SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

Method of using insulin for controlling glycosylation of recombinant glycoprotein

Immunotherapy against ErbB-3 receptor

Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same

Method of protein manufacture

Cell-permeable peptide system for treating diseases caused by glutamate excitotoxicity

Chimeric antigen receptor and methods of use thereof

Method of Identifying Transmembrane Protein-interacting Compounds

CHIMERIC PROTEIN

SURVIVIN SPECIFIC T-CELL RECEPTOR TARGETING TUMOR BUT NOT T CELLS

Bruton's tyrosine kinase as anti-cancer drug target

ANTI-TUMOR ANTIBODY-TUMOR SUPPRESSOR FUSION PROTEIN COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF CANCER

SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same

Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

Methods of treating liver conditions using Notch2 antagonists

Efficient delivery of therapeutic molecules to cells of the inner ear

Methods for synthesizing α4β7 peptide antagonists

Peptide inhibitors of sodium channels

GLYCOSYLATION MUTANTS FOR PRODUCING GALACTOSE-FREE AND FUCOSE-FREE POLYPEPTIDES

Isolated nucleic acid encoding an anti-IGF-1R antibody

Fragments of syndecan-2 having anti-angiogenic activity

RANKL-specific agent for treating metastatic disease

METHOD FOR SCREENING COMPOUND SPECIFICALLY SUPPRESSING FORMATION OF CAVEOLAE OF CANCER CELLS, SCREENING KIT, VECTOR AND TRANSFORMANT TO BE USED IN KIT, AND METHOD FOR SELECTING PATIENT FOR WHOM MOLECULARLY TARGETED DRUG IS INDICATED

Multimeric coding nucleic acid and uses thereof

T1R taste receptors and genes encoding same

Optogenetic probes for measuring membrane potential

Inhibitors of mitochondrial fission and methods of use thereof

Methods for treating central or peripheral nervous system damage

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

Human Notch1 decoys

EGFR and c-Met fibronectin type III domain binding molecules

Vascular endothelial growth factor fusion protein

Tmem100 peptides and variants thereof and their use in treating or preventing diseases or conditions

METHODS FOR REDUCING CD36 EXPRESSION

Epitope as a target for therapy of inflammatory autoimmune diseases and graft rejection

Treatment of hormonal disorders of growth

Dab2 inhibitors for the prevention and treatment of cystic fibrosis

Substances and methods for the use in prevention and/or treatment in Huntington's disease

Loss of function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits

Methods and compositions for transducing lymphocytes and regulated expansion thereof

Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

Bis-sulfhydryl macrocyclization systems

Biomarkers for risk assessment, diagnosis and target microbiome and intestinal homeostasis for prevention and treatment of amyotrophic lateral sclerosis

Method for modulating car-induced immune cells activity

Chimeric antigen receptor specific for SSEA4 antigen

Peptides having reduced toxicity that stimulate cholesterol efflux

COMPOSITIONS AND METHODS TO SELECTIVELY BLOCK PAIN INDUCED BY COLD

Methods and compositions for the treatment of cancer

Trophoblast glycoprotein (5T4, TPBG) specific chimeric antigen receptors for cancer immunotherapy

Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods

Nucleic acids, vectors, host cells, and methods for recombinantly producing water-soluble membrane proteins

Inhibiting the transient receptor potential A1 ion channel

Methods for increasing red blood cell levels and treating ineffective erythropoiesis

Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury

Feline bitter taste receptors and methods

Tagged chimeric effector molecules and receptors thereof

Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma

TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch

Treatment of diabetes, toll-like receptor 4 modulators and methods for using the same

Functionalized beta-sheet peptide stabilized membrane proteins, constructs comprising same, and methods of forming and using same

Compositions and methods of stimulating and expanding T cells

Method for detecting and purifying pancreatic beta cells

Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers

Binding domains directed against GPCR:G protein complexes and uses derived thereof

Methods for the isolation of extracellular vesicles and other bioparticles from urine and other biofluids

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIES

BIPARTITE AND TRIPARTITE SIGNALING IMMUNE CELLS

Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders

Cleavage-activatable interferon-alpha proprotein

Methods and compositions for the treatment of radiation-related disorders

Binding-triggered transcriptional switches and methods of use thereof

Chimeric antigen receptor containing a toll-like receptor intracellular domain

Virus like particle comprising PD-1 antigen or PD-1 ligand antigen

Peptide inhibitors of sodium channels

Polypeptides, related nucleic acids, and their uses for cell modulation and treatments

Methods and compositions for treating cancer

Solid phase peptide synthesis

COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY

CELL LINES EXPRESSING NaV AND METHODS OF USING THEM

Application of TRPM8 protein, related peptide fragment and their antibodies

PANCREATIC CANCER TARGETS AND USES THEREOF

Wnt Antagonists and Methods of Treatment and Screening

Peptide compounds for inhibitions of platelet aggregation

CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF

Methods for improving cardiac function by administering an antibody that activates APLNR

MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions

HBV epitope reactive exogenous T cell receptor (TCR) and uses thereof

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

Feline bitter taste receptors and methods

Polypeptides derived from calcitonin receptors and methods of use

Engineered receptor and their use

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Bruton's tyrosine kinase as anti-cancer drug target

Tyrosine kinase biosensors and methods of use

Methods of inhibiting pathological angiogenesis with doppel-targeting molecules

Opioid receptor binding agents and uses thereof

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

Composition for delivery of genetic material

Breast and ovarian cancer vaccines

Isolation and use of solid tumor stem cells

Kv2.1 channel-derived peptides and methods of use

Protein-based molecular temperature switch

PERSONALIZED TREATMENT OF CANCER USING FGFR INHIBITORS

Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins

Macrophage CAR (MOTO-CAR) in immunotherapy

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Sperm-Specific Cation Channel, Catsper2, and Uses Therefor

METHOD FOR MANUFACTURING TRANSGENIC PLANT PRODUCING IMMUNOGENIC COMPLEX PROTEINS AND IMMUNOGENIC COMPLEX PROTEINS OBTAINED THEREFROM

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

Substrates for detection of botulinum neurotoxin

Phoenixin peptides

Chimeric antigen receptor and methods of use thereof

Methods for improving the efficacy and expansion of immune cells

Protease-activated receptor-2 modulators

PEPTIDES, AND METHODS AND APPARATUS UTILISING SAME

Kv1.3 potassium channel antagonists

Cell-permeable peptide system for treating diseases caused by glutamate excitotoxicity

Compositions and methods for promoting wound healing and tissue regeneration

Fusion proteins and uses thereof

Chloride salt of TAT-NR2B9c

G-protein-coupled-receptor-22-transformed cell lines and methods of use thereof to identify binding compounds

Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease

Chimeric antigen receptors targeting CD-19

Sperm-Specific Cation Channel, and Uses Therefor

LDLR variants and their use in compositions for reducing cholesterol levels

Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereof